How to Protect Football Stars
Experts discuss multiple avenues OSHA could undertake to protect NFL players.
The Unhealthy Return to Individual Responsibility in Health Policy
The Republicans’ ACA replacement plan espouses individual responsibility—a naïve and ill-advised approach to healthcare reform.
When the Health Care Market Cannot Regulate Itself
Vermont moves to an all-payer system in regulating prices for health care services.
FDA Takes Action to Curb Overuse of Antimicrobials in Livestock
Amid growing concerns about “superbugs,” regulators seek comment on use of antimicrobials in animal feed.
Time to Get Graphic with Cigarette Labels?
FDA is years behind in its statutory mandate to put graphic warnings on cigarette labels.
The Uncertain Benefits of GMO Labeling
Scholar argues that regulators will have difficulty applying cost-benefit analysis to mandatory GMO labeling.
Do We Know How Risky E-Cigarettes Are?
E-cigarettes are less dangerous than is generally believed, posing a unique information challenge for regulators.
A More Holistic Definition of “Healthy”
Regulator solicits input on a new rule defining when foods could be considered “healthy.”
Drug Price Lowering Solutions from the Campaign Trail
As drug prices spike, the presidential candidates endorse proposals for getting costs down.
How OSHA Can Succeed with the Cards It Is Dealt
Despite its wide-ranging capabilities, OSHA has often let its detractors have their way. To combat this, it should enlist partners in all directions.
If We Can Fix TSCA, We Can Fix the OSH Act
President Obama recently signed toxics reform; now it is time to fix workplace safety law, too.
For Hepatitis Drugs, Availability Does Not Equal Access
Is the government willing to infringe on drug patents to curb a public health crisis?